Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
U.S.
Local
World
Science
Technology
Entertainment
Business
Sports
More
Politics
Trending on Bing
Mob ransacks CA mini-mart
Missing cruise teen found
Donors demand resignation
Blames 'internet culture'
49 drowned across Russia
Judge declines to dismiss suit
Actress Belushi-Pisano dies
Loses deals following arrest
Lake fire grows: 12K acres
Pays tribute to Jon Landau
11 killed in Nepal landslides
Judge pauses some deadlines
RU wrestlers reject invitation
Mars mission wraps up
'Moana' in the works
Speaks at Essence Festival
Frozen garbage on Everest
PA Capitol bomb threat
Hamas awaits ISR response
Criticizes US-China chip war
Israelis push Gaza deal
Remains found in sleeping bag
NBA Summer League debut
Notches 1,000th career hit
Beats Artem Harutyunyan
NJ forest fire 65% contained
Rookie's historic game
'Cross' sets premiere date
NBA free agency 2024
Nate Diaz beats Masvidal
Drops 'Not Like Us' video
Job scams surge in 2023
Brad Pitt's new 'F1' film
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA, Alzheimer
FDA approves new early-stage Alzheimer's drug
According to the Alzheimer's Association, more than 129,000 people aged 65 and older have Alzheimer's disease in Tennessee.
FDA approves a second Alzheimer’s drug that can modestly slow disease
U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that's been convincingly shown to slow the memory-destroying condition.
FDA approves a new Alzheimer's drug. What to know about Eli Lilly's Kisunla
The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
Yahoo Style UK on MSN
1d
'Microdosing' candies linked to illness, death, and a new Alzheimer's drug: A look at health stories you may have missed
Hello, health and wellness readers. My name is Kaitlin, your guide to the latest health news you may have missed. First, ...
1d
on MSN
'It's a sad, sad disease': Local researchers work to bring new Alzheimer's drugs to patients
Doctors at the Roskamp Institute aim to treat around 10,000 patients a year with the new drugs and provide resources to area ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Eli Lilly and Company
Kisunla
Feedback